New Study Finds Link Between This Common Virus and Alzheimer’s Disease: What A Neurologist Wants You To Know
The researchers found the presence of CMV antibodies all over patients with Alzheimer's disease, including the intestines, spinal fluid, brains, and vagus nerves. The scientists found similar findings in an independent group of patients with Alzheimer’s disease.
How a Common Virus Could Trigger Alzheimer’s Disease
Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein,
Herpes virus and repeated head trauma linked to Alzheimer’s, study finds
The research at Tufts and Oxford universities, using stem cells turned to organoids or “brains in a dish”, offers more evidence that viruses, particularly those in the herpes family that are present in the majority of adults,
Researchers Found A Link Between This Childhood Virus And Alzheimer's. Here's What A Neurologist Wants You To Know
A new study found a link between cytomegalovirus (CMV) and Alzheimer's disease. Here's what a neurologist wants you to know, plus how to protect yourself.
Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Hosted on MSN4h
Alzheimer’s disease cases in 8MM to reach 22.51 million by 2033
China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...
Early Signs of Alzheimer's Women Should Not Ignore, According to Neurology Expert
Alzheimer’s disease is the most common cause of dementia in older adults. But according to experts, the condition affects men ...
IGC Pharma Names IGC-AD1 Phase 2 Clinical Trial for Alzheimer’s Agitation “CALMA” and Expands Recruitment Strategy
POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
Johnson & Johnson Gets FDA Fast-Track Designation for Posdinemab in Alzheimer's
The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
Daily Herald4d
As a doctor, here’s what I have learned from my own Alzheimer’s disease
I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...
KSL6d
What we learned about Alzheimer's disease in 2024
SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 ...
Science Daily1d
Alzheimer's News
Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.
STAT9d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
What we know about Alzheimer’s disease in 2024
The Alzheimer’s Association reports that the disease begins as many as two decades before symptoms develop. Physically, the ...
Biomarker and Trial Optimisation Needed to Drive R&D Progress in Alzheimer’s and Related Disorders – ICON Survey
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...